From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
Combining Both Methods In some cases, a combined approach is used
Always consult a qualified healthcare provider before beginning any peptide therapy program
gently massage the area if tender Hydrate well for optimal absorption Minor redness, warmth, or soreness may occur and resolve quickly Contact us for any unusual symptoms Pricing & Booking Single B12 Shot: $30 Series (48): $108-$204 (save 10-15%) Ready to feel your best
Frequently Asked Questions About the Peptide Half-Life Chart What is a peptide half-life chart and why does it matter
Mood enhancement becomes more pronounced at four to six weeks